Northvale, New Jersey--(Newsfile Corp. - April 2, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today...
Conference Call Scheduled for Wednesday, February 18 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - February 17, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"),...
Financials for Third Quarter of Fiscal Year 2026 Ended December 31, 2025 will be released on Tuesday, February 17, 2026Northvale, New Jersey--(Newsfile Corp. - February 11, 2026) - Elite Pharmaceuticals,...
Conference Call Scheduled for Monday, November 17 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...
Northvale, New Jersey--(Newsfile Corp. - November 12, 2025) - Elite Pharmaceuticals, Inc. (OTCBB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products,...
Financials for Second Quarter of Fiscal Year 2026 Ended September 30, 2025 will be released on Friday, November 14, 2025Northvale, New Jersey--(Newsfile Corp. - November 10, 2025) - Elite Pharmaceuticals,...
Shares of Elite Pharmaceuticals, Inc. ELTP have gained 6.3% since the company reported its earnings for the quarter ended June 30, 2025. This compares to the S&P 500 Index’s 1.1% loss over the same time...
Conference Call Scheduled for Friday, August 15 at 11:30 AM EDTNorthvale, New Jersey--(Newsfile Corp. - August 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...
Here we highlight 2 small cap stocks with Zacks’ Outperform ratings that pulled back despite recent quarterly announcements which were arguably strong but a bit noisy.Elite Pharmaceuticals Inc. (ELTP)...
Financials for First Quarter of Fiscal Year 2026 Ended June 30, 2025 will be released on Thursday, August 14, 2025Northvale, New Jersey--(Newsfile Corp. - August 8, 2025) - Elite Pharmaceuticals, Inc. (OTCQB:...